All persons or entities that purchased or otherwise acquired during the period between November 14, 2016 and December 8, 2021, inclusive, you purchased or otherwise acquired the common stock of Reata Pharmaceuticals, Inc. (“Reata” or the “Company”), including Reata common stock purchased or otherwise acquired pursuant and/or traceable to Reata’s 2019 Offering and/or 2020 Offering
Final Approval
November 14, 2016 - June 20, 2022
March 29, 2024
March 08, 2024
Epiq
Doyle v. Reata Pharmaceuticals, Inc.
c/o Epiq
P.O. Box 5566
Portland, OR 97228-5566
+1 877-664-7398
info@ReataSecuritiesLitigation.com
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.